What is the appropriate next step in management for a pregnant patient at 37 weeks of gestation with a fundal height corresponding to 35 weeks and absent end-diastolic flow on umbilical artery Doppler (Umbilical Artery Doppler Ultrasound)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Delivery by Caesarean Section (Option B)

At 37 weeks gestation with absent end-diastolic flow (AEDF) on umbilical artery Doppler, immediate delivery by caesarean section is the appropriate next step in management.

Rationale for Immediate Cesarean Delivery

AEDF at 37 weeks represents a critical situation where the fetus has already exceeded the recommended delivery window of 33-34 weeks, making immediate delivery mandatory rather than expectant management. 1, 2

  • AEDF indicates severe placental insufficiency with obliteration of approximately 70% of placental tertiary villi arteries, creating a high-risk situation that mandates delivery 1
  • The Society for Maternal-Fetal Medicine recommends delivery at 33-34 weeks of gestation for pregnancies with fetal growth restriction and AEDF 3, 2
  • Delaying delivery beyond 34 weeks in cases of AEDF significantly increases the risk of adverse outcomes 2
  • Perinatal death occurs in >20% of pregnancies with AEDF, with significantly worse outcomes when vaginal delivery is attempted 1

Why Cesarean Section Over Induction

Labor induction should never be attempted with AEDF, as the fetus cannot tolerate the stress of contractions given the severe placental insufficiency. 1

  • AEDF is the most predictive Doppler finding for adverse perinatal outcomes, outperforming other antenatal tests like NST and biophysical profile 1
  • National guidelines from multiple countries recommend cesarean delivery when fetal growth restriction is complicated by AEDF 3
  • Growth-restricted fetuses with AEDF are at increased risk for intrapartum fetal heart rate decelerations requiring emergency cesarean delivery and metabolic acidemia at delivery 3

Why Not Repeat Doppler in 1 Week

At 37 weeks gestation, this fetus is already 3-4 weeks past the recommended delivery window for AEDF (33-34 weeks), making further surveillance inappropriate. 3, 2

  • Intensive surveillance protocols (daily cardiotocography, twice-weekly Doppler) are only appropriate for AEDF diagnosed before 34 weeks gestation 2
  • The clinical scenario demands rapid delivery given the advanced gestational age combined with severe fetal compromise 4

Critical Clinical Pitfalls to Avoid

  • Never attempt labor induction or augmentation with AEDF - the fetus cannot tolerate the stress of contractions 1
  • Do not delay delivery beyond 34 weeks in AEDF cases, as this significantly increases adverse outcomes 2
  • Distinguish AEDF from reversed end-diastolic flow (REDF), which is even more severe and requires earlier delivery at 30-32 weeks 3, 2
  • Avoid managing AEDF without specialist consultation, as these cases require experienced obstetric or maternal-fetal medicine involvement 1

Pre-Delivery Management

  • Obtain cord arterial and venous pH at delivery to assess the degree of fetal compromise 1
  • Send the placenta for histopathologic examination to guide future pregnancy management 1, 2

References

Guideline

Management of Absent End-Diastolic Flow in Umbilical Artery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Absent End Diastolic Flow in Fetal Monitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Immediate Cesarean Section Indications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the most appropriate immediate management for a patient at 38 weeks' gestation in labor with a 7cm dilated cervix, full effacement, and vertex, who has a loop of the umbilical cord below the fetal head?
What is the management for subdiaphragmatic air post cesarean?
What is the most important intervention for a fetus with bradycardia and prolonged contraction during labor induction?
What is the most appropriate management for a patient at 38 weeks of gestation in active labor with 6 cm cervical dilation, fetal tachycardia (baseline 120 beats per minute), absent accelerations and variability, recurrent late decelerations on cardiotocography, and strong frequent uterine contractions?
What is the next best step in management for a 39-week pregnant woman with severe abdominal pain, heavy vaginal bleeding, hypotension, and a dilated cervix?
How to manage renal recovery in patients with impaired renal function due to amphotericin B (antifungal medication)?
What are the indications for irradiating blood products for transfusion?
What is the recommended treatment for a facial hematoma?
What is the recommended dose of Tamiflu (oseltamivir) for treating influenza?
Can pigmented purpuric dermatoses (PPD) progress to cutaneous T cell lymphoma (CTCL) and what are the red flags that necessitate a skin biopsy to exclude CTCL?
What is the next step for a 58-year-old female with atypical squamous cells of undetermined significance (ASC-US) and a positive high-risk Human Papillomavirus (HPV) test?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.